Clinical trial
A Randomized Phase III of Adjuvant Targeted Radionuclide Therapy With In111-Pentetreotide in Patients With Digestive Neuroendocrine Tumors After Complete Surgical Resection of Liver Metastases.
NCT02465112 is registered in ClinicalTrials.gov with GERCOR - Multidisciplinary Oncology Cooperative Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Phase III of Adjuvant Targeted Radionuclide Therapy With In111-Pentetreotide in Patients With Digestive Neuroendocrine Tumors After Complete Surgical Resection of Liver Metastases.
- Lead sponsor
- GERCOR - Multidisciplinary Oncology Cooperative Group
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- September 30, 2015
- Completion date
- October 11, 2018
- Enrollment
- 4 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
digestive neuroendocrine tumors, liver metastases, metabolic radiotherapy, resection